Cargando…
Computationally driven discovery of SARS-CoV-2 M(pro) inhibitors: from design to experimental validation
We report a fast-track computationally driven discovery of new SARS-CoV-2 main protease (M(pro)) inhibitors whose potency ranges from mM for the initial non-covalent ligands to sub-μM for the final covalent compound (IC(50) = 830 ± 50 nM). The project extensively relied on high-resolution all-atom m...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8966641/ https://www.ncbi.nlm.nih.gov/pubmed/35432906 http://dx.doi.org/10.1039/d1sc05892d |